Join us for MedDev Day Virtual 2020 on 22nd September! During this second edition of the MedDev Day industry experts will share their experience and real-life examples on how to reach the MDR compliance. The event will address topics such as: The EU perspective: Latest developments in MDR implementation regulations, Common Specifications and Clinical Guidance…

Post-authorization studies (PAS): European & American approach Randomized trials are the gold standard in evaluating the efficacy of new healthcare interventions. However, despite their ability to potentially provide causal estimates of the efficacy of new treatments, their general nature in relation to patients in the real world is often unclear. Strict exclusion criteria may lead…

On the 10th of October the top industry professionals gathered in Madrid, Spain, for Regulatory Day, an immersive workshop organized by seQure in collaboration with other PM Holding companies and its partners Oracle Health Sciences and Asphalion. The event, entitled “Breaking Down The Silos: Product Development Journey through Post-Marketing: EMA vs FDA” brought together the…

Verona, Italy (11 September 2019) – PM Holding, a group of diverse service providers in the life sciences industry, announces the appointment of Angela Weston as Chief Commercial Officer to manage business development operations across the entire group. PM Holding consists of specialized service providers in the drug and device development sector including: CROS NT…

Event titled “Breaking Down The Silos: Product Development Journey through Post-Marketing: EMA vs FDA” will take place in Madrid on 10th October The PM Holding group of companies including CROS NT, Arithmos, and seQure are excited to announce a Regulatory Day workshop, a unique event in collaboration with Oracle and Asphalion that focuses on the…

With the new ICH GCP E6(R2) addendum in effect from June 14, 2017, seQure Life Sciences would like to highlight: “The importance of a quality management system managed through a risk-based approach”.  The new addendum is the largest revision of the ICH GCP Guidelines over the past twenty years and it is fully supported by the…

seQure Life Sciences presents the current pharmacovigilance legislation in Europe:

©2017 - seQure - All Right Reserved - Privacy Policy - Cookie Policy